Last updated on July 2006

Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD) | Insomnia
  • Age: Between 6 - 17 Years
  • Gender: Male or Female
  • Other:
    Boy or girl aged 6-17 years, inclusive, and English-speaking
    Meet the DSM-IV criteria for Attention-Deficit/Hyperactivity Disorder
    Have sleep initiation defined by:
    difficulty initiating or maintaining sleep that is viewed as a problem by the
    child or caregiver
    sleep onset delay that is not exclusively related to direct or rebound effects
    of psychostimulant treatment
    Have a parent or legal guardian willing to participate in the study

You may not be eligible for this study if the following are true:

  • Have any other primary sleep disorder(s) (e.g. obstructive sleep apnea or periodic
    limb movement disorder)
    Have a history of significant chronic medical (e.g. diabetes, severe asthma) or
    psychiatric (e.g. depression) illness
    Have a history of chronic use of sedating (e.g. antihistamines) or alertness
    enhancing (e.g. caffeine) medications
    Have a history of failure to respond to an adequate (defined as appropriate dose and
    adequate duration of therapy) previous trial with atomoxetine

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.